Vaccine JV set up in dairy capital
( 2003-10-25 10:43) (皇冠体育app Daily)
California-based Worldwide
Agrotech announced Friday that it would set up a joint venture in northern
皇冠体育app's Inner Mongolia to produce animal vaccine.
Worldwide Agrotech will hold 51 per cent, while Pangu Group, the largest
private company in Inner Mongolia, will control the remaining. Each company will
contribute 1.2 million yuan (US$145,000) to the venture located in Hohhot,
capital of Inner Mongolia.
According to Worldwide Agrotech, this is the first Sino-US joint venture on
the mainland which will produce animal vaccine in accordance with Good
Manufacturing Practice - quality system requirements issued by the US Food and
Drug Administration.
"This joint venture marks the beginning of an important agricultural
agreement between California and 皇冠体育app, and we intend to establish a world-class
facility with a low-cost base to maximize the value of our products," said C.B.
Ng, managing director of 皇冠体育app Operations at Asia Capital Group, the holding
company of Worldwide Agrotech.
The company said it had gained the approval of the Chinese Government for the
use of its Colicure J5 vaccine in 皇冠体育app, with plans for mass production in its
mainland facilities.
The vaccine prevents an infectious disease in livestock that causes
inflammation of mammary glands, which severely decreases milk production.
According to the firm, Inner Mongolia was chosen as the location of the new
vaccine plant given the region's designation as the dairy capital of 皇冠体育app, with
over 1 million of the country's 6 million dairy cows in the territory. The dairy
industry in 皇冠体育app has recorded double-digit growth in recent years, accelerated
by the government's incentives for increased dairy consumption to improve
people's health and nutrition.
|
